WASHINGTON (Reuters) - Democrats in the U.S. House of Representatives unveiled a sweeping healthcare overhaul on Thursday that would transform the insurance market, create a government-run insurance plan and levy new taxes on the rich.

WASHINGTON (Reuters) - When pregnant women get vaccinated against flu, their babies are bigger, healthier and less likely to be premature, researchers reported on Thursday.

NEW YORK (Reuters Health) - These are heady days for the medical tourism industry. With U.S. healthcare prices spiraling upward, more and more insurers and individuals are looking abroad for treatment. By some estimates, 650,000 Americans will check into foreign hospitals from Mexico to Thailand this year.

CHICAGO (Reuters) - U.S. researchers have found a way to coax human embryonic stem cells to turn into the types of cells that make eggs and sperm, shedding light on a stage of early human development that has not been fully understood.

PHOENIX (Reuters) - Including a government-run insurance option in a U.S. healthcare bill has split lawmakers in the Democrat-controlled U.S. Congress, but support for it remains broad on the streets of U.S. cities, voters and pollsters say.

WASHINGTON (Reuters) - The U.S. government may end up throwing away unused doses of swine flu vaccine if people cannot get it soon enough, the director of the U.S. Centers for Disease Control and Prevention said on Tuesday.

LONDON (Reuters) - More than 5,500 children across Africa have been given an experimental new malaria vaccine and the British drugmaker behind it, GlaxoSmithKline, promised on Wednesday that price would be no hurdle if it works.

WASHINGTON (Reuters) - Democratic leader Harry Reid said on Monday the Senate’s healthcare overhaul will include a government-run insurance plan that lets states opt out, handing liberals an early victory on the bill’s most contentious issue.

WASHINGTON (Reuters) - The U.S. healthcare system is just as wasteful as President Barack Obama says it is, and proposed reforms could be paid for by fixing some of the most obvious inefficiencies, preventing mistakes and fighting fraud, according to a Thomson Reuters report released on Monday.

CHICAGO (Reuters) - The federal government’s push to control health costs through comparative effectiveness research could threaten strides in personalized medicine, in which medicines are tailored to an individual’s genetic makeup, the chief of the National Institutes of Health said on Monday.